Application 078876
- Type
- ANDA
- Sponsor
- LANNETT CO INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CETIRIZINE HYDROCHLORIDE | CETIRIZINE HYDROCHLORIDE | SYRUP;ORAL | 5MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 54838-571 | Cetirizine Hydrochloride | Cetirizine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 54838-571 | Cetirizine Hydrochloride | Cetirizine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 54838-571 | Cetirizine Hydrochloride | Cetirizine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 54838-572 | Cetirizine Hydrochloride | Cetirizine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 54838-572 | Cetirizine Hydrochloride | Cetirizine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 54838-572 | Cetirizine Hydrochloride | Cetirizine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 62135-057 | Cetirizine Hydrochloride Oral Solution | Cetirizine Hydrochloride Oral Solution | Chartwell RX, LLC | ANDA | Current |